Rapamune
( DrugBank: - / KEGG DRUG: - )
7 diseases
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
158 | 結節性硬化症 | 6 |
278 | 巨大リンパ管奇形(頚部顔面病変) | 2 |
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 3 |
60. 再生不良性貧血
臨床試験数 : 305 / 薬物数 : 328 - (DrugBank : 91) / 標的遺伝子数 : 60 - 標的パスウェイ数 : 183
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
66. IgA腎症
臨床試験数 : 349 / 薬物数 : 251 - (DrugBank : 75) / 標的遺伝子数 : 43 - 標的パスウェイ数 : 152
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
67. 多発性嚢胞腎
臨床試験数 : 233 / 薬物数 : 188 - (DrugBank : 54) / 標的遺伝子数 : 60 - 標的パスウェイ数 : 165
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
84. サルコイドーシス
臨床試験数 : 175 / 薬物数 : 189 - (DrugBank : 80) / 標的遺伝子数 : 74 - 標的パスウェイ数 : 177
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
158. 結節性硬化症
臨床試験数 : 129 / 薬物数 : 56 - (DrugBank : 20) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 116
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
278. 巨大リンパ管奇形(頚部顔面病変)
臨床試験数 : 32 / 薬物数 : 32 - (DrugBank : 12) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 136
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
280. 巨大動静脈奇形(頚部顔面又は四肢病変)
臨床試験数 : 29 / 薬物数 : 31 - (DrugBank : 15) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 163
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|